Abstract
NF-κB is known to exert a cytoprotective action against TNF-α-induced apoptosis. To study the role of NF-κB in various TNF-α-treated epithelial cell lines, we generated stable transfectants overexpressing a mutated unresponsive form of the IκBα inhibitor (MT cells). As NF-κB prevented TNF-α-induced apoptosis in various epithelial cancer cell lines, we searched for NF-κB target gene products responsible for this difference of sensitivity. We observed an increased Bcl-XL expression level in OVCAR-3 cells compared with OVCAR-3 cells expressing a mutated IκBα inhibitor (MT cells). Induction of the antioxidant enzyme MnSOD was detected only in TNF-α-treated OVCAR, MCF7A/Z and HCT116 cells but not in MT cells. Moreover, reactive oxygen species were involved in TNF-α-induced apoptosis, as various antioxidants partially protected these cells from apoptosis. At last, transfection of the MnSOD cDNA in MT cells, which do not express this protein after TNF-α stimulation, partially restored resistance to TNF-α-induced cell death, as observed by clonogenic assays. However, transfection of the Bcl-XL cDNA did not induce any protective effect. Therefore, MnSOD expression is induced by NF-κB in epithelial cancer cells in response to TNF-α, and is at least partially responsible for their resistance to TNF-α-induced apoptosis, presumably through the clearance of death-inducing ROS.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Adams JM, Cory S . 1998 Science 281: 1322–1326
Aggarwal BB . 2000 Biochem. Pharmacol. 60: 1033–1039
Ashkenazi A, Dixit VM . 1998 Science 281: 1305–1308
Barkett M, Gilmore TD . 1999 Oncogene 18: 6910–6924
Beg AA, Baltimore D . 1996 Science 274: 782–784
Bentires-Alj M, Hellin AC, Ameyar M, Chouaib S, Merville MP, Bours V . 1999 Cancer Res. 59: 811–815
Bernard D, Quatannens B, Begue A, Vandenbunder B, Abbadie C . 2001 Cancer Res. 61: 2656–2664
Beyaert R, Fiers W . 1998 Tumor Necrosis Factor and Lymphotoxin Cytokines Mire-Sluis A and Thorpe R. (ed) London Academic Press pp 335–360
Bonizzi G, Dejardin E, Piret B, Piette J, Merville MP, Bours V . 1996 Eur. J. Biochem. 242: 544–549
Bonizzi G, Piette J, Merville MP, Bours V . 1997 J. Immunol. 159: 5264–5272
Bonizzi G, Piette J, Merville MP, Bours V . 2000 Biochem. Pharmacol. 59: 7–11
Bonizzi G, Piette J, Schoonbroodt S, Greimers R, Havard L, Merville MP, Bours V . 1999 Mol. Cell. Biol. 19: 1950–1960
Bours V, Bentires-Alj M, Hellin AC, Viatour P, Robe P, Delhalle S, Benoit V, Merville MP . 2000 Biochem. Pharmacol. 60: 1085–1089
Chao DT, Korsmeyer SJ . 1998 Annu. Rev. Immunol. 16: 395–419
Chen C, Edelstein LC, Gelinas C . 2000 Mol. Cell. Biol. 20: 2687–2695
Church SL, Grant JW, Ridnour LA, Oberley LW, Swanson PE, Meltzer PS, Trent JM . 1993 Proc. Natl. Acad. Sci. U.S.A 90: 3113–3117
Darville MI, Ho YS, Eizirik DL . 2000 Endocrinology 141: 153–162
Dejardin E, Bonizzi G, Bellahcene A, Castronovo V, Merville MP, Bours V . 1995 Oncogene 11: 1835–1841
Drane P, Bravard A, Bouvard V, May E . 2001 Oncogene 20: 430–439
Duan H, Dixit VM . 1997 Nature 385: 86–89
Feuillard J, Schuhmacher M, Kohanna S, Asso-Bonnet M, Ledeur F, Joubert-Caron R, Bissieres P, Polack A, Bornkamm GW, Raphael M . 2000 Blood 95: 2068–2075
Fiers W, Beyaert R, Brouckaert P, Everaerdt B, Haegeman C, Suffys P, Tavernier J, Vanhaesebroeck B . 1988 Dev. Biol. Stand. 69: 143–151
Finco TS, Westwick JK, Norris JL, Beg AA, Der CJ, Baldwin Jr AS . 1997 J. Biol. Chem. 272: 24113–24116
Gibbs LS, Del Vecchio PJ, Shaffer JB . 1992 Free Radic. Biol. Med. 12: 107–111
Goossens V, De Vos K, Vercammen D, Steemans M, Vancompernolle K, Fiers W, Vandenabeele P, Grooten J . 1999 Biofactors 10: 145–156
Gottlieb E, Vander Heiden MG, Thompson CB . 2000 Mol. Cell. Biol. 20: 5680–5689
Gross A, McDonnell JM, Korsmeyer SJ . 1999 Genes Dev. 13: 1899–1911
Grumont RJ, Rourke IJ, Gerondakis S . 1999 Genes Dev. 13: 400–411
Gwinner W, Tisher CC, Nick HS . 1995 Kidney Int. 48: 354–362
Hellin AC, Calmant P, Gielen J, Bours V, Merville MP . 1998 Oncogene 16: 1187–1195
Jacoby DB, Choi AM . 1994 Free Radic. Biol. Med. 16: 821–824
Karin M . 1999 Oncogene 18: 6867–6874
Kifle Y, Monnier J, Chesrown SE, Raizada MK, Nick HS . 1996 J. Neurochem. 66: 2128–2135
Kim KH, Rodriguez AM, Carrico PM, Melendez JA . 2001 Antioxid. Redox. Signal. 3: 361–373
Larsen CJ . 1994 Ann. Genet. 37: 121–134
Lebovitz RM, Zhang H, Vogel H, Cartwright Jr J, Dionne L, Lu N, Huang S, Matzuk MM . 1996 Proc. Natl. Acad. Sci. U.S.A 93: 9782–9787
Lee HH, Dadgostar H, Cheng Q, Shu J, Cheng G . 1999 Proc. Natl. Acad. Sci. U.S.A 96: 9136–9141
Li JJ, Oberley LW, St Clair DK, Ridnour LA, Oberley TD . 1995b Oncogene 10: 1989–2000
Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura MP, Berger C, Chan PH . 1995a Nat. Genet. 11: 376–381
Lo YY, Cruz TF . 1995 J. Biol. Chem. 270: 11727–11730
Lo YY, Wong JM, Cruz TF . 1996 J. Biol. Chem. 271: 15703–15707
Macmillan-Crow LA, Cruthirds DL . 2001 Free Radic. Res. 34: 325–336
Manna SK, Zhang HJ, Yan T, Oberley LW, Aggarwal BB . 1998 J. Biol. Chem. 273: 13245–13254
Oberley LW . 2001 Antioxid. Redox. Signal. 3: 461–472
Oberley LW, Buettner GR . 1979 Cancer Res. 39: 1141–1149
Pahl HL . 1999 Oncogene 18: 6853–6866
Reed JC . 1998 Oncogene 17: 3225–3236
Ryan KM, Ernst MK, Rice NR, Vousden KH . 2000 Nature 404: 892–897
Strasser A, O'Connor L, Dixit VM . 2000 Annu. Rev. Biochem. 69: 217–245
Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM . 1996 Science 274: 787–789
Vander Heiden MG, Thompson CB . 1999 Nat. Cell Biol. 1: E209–E216
Wang CY, Cusack Jr JC, Liu R, Baldwin Jr AS . 1999 Nat. Med. 5: 412–417
Wang CY, Mayo MW, Baldwin Jr AS . 1996 Science 274: 784–787
Xu Y, Kiningham KK, Devalaraja MN, Yeh CC, Majima H, Kasarskis EJ, St Clair DK . 1999 DNA Cell. Biol. 18: 709–722
Zhao Y, Xue Y, Oberley TD, Kiningham KK, Lin SM, Yen HC, Majima H, Hines J, St Clair D . 2001 Cancer Res. 61: 6082–6088
Zong WX, Edelstein LC, Chen C, Bash J, Gelinas C . 1999 Genes Dev. 13: 382–387
Acknowledgements
The authors are grateful to Dr Chouaib (IGR, Villejuif, France) for the gift of the MnSOD cDNA, and to Dr Bertrand (Université de Montréal, Canada) for the gift of the Bcl-XL plasmid. M-P Merville is a Research Associate and V Benoit is a Research Assistant of the National Fund for Scientific Research. (‘FNRS’, Belgium). S Delhalle is supported by a Télévie grant (Belgium), and V Deregowski is supported by the Centre Anti Cancéreux (University of Liège, Belgium). This work was supported by grants from the National Fund for Scientific Research (‘FNRS’), and the ‘Centre Anti-Cancéreux’ (Liège, Belgium).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Delhalle, S., Deregowski, V., Benoit, V. et al. NF-κB-dependent MnSOD expression protects adenocarcinoma cells from TNF-α-induced apoptosis. Oncogene 21, 3917–3924 (2002). https://doi.org/10.1038/sj.onc.1205489
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205489
Keywords
This article is cited by
-
Glutathione peroxidase-1 regulates ASK1-dependent apoptosis via interaction with TRAF2 in RIPK3-negative cancer cells
Experimental & Molecular Medicine (2021)
-
Life, death, and autophagy in cancer: NF-κB turns up everywhere
Cell Death & Disease (2020)
-
Thalidomide potentiates etoposide-induced apoptosis in murine neuroblastoma through suppression of NF-κB activation
Pediatric Surgery International (2018)
-
ATM is required for SOD2 expression and homeostasis within the mammary gland
Breast Cancer Research and Treatment (2017)
-
Gene expression profile of compressed primary human cementoblasts before and after IL-1β stimulation
Clinical Oral Investigations (2014)